164 related articles for article (PubMed ID: 9442985)
1. Accelerating response in geriatric depression: a pilot study combining sleep deprivation and paroxetine.
Bump GM; Reynolds CF; Smith G; Pollock BG; Dew MA; Mazumdar S; Geary M; Houck PR; Kupfer DJ
Depress Anxiety; 1997; 6(3):113-8. PubMed ID: 9442985
[TBL] [Abstract][Full Text] [Related]
2. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.
Smith GS; Reynolds CF; Pollock B; Derbyshire S; Nofzinger E; Dew MA; Houck PR; Milko D; Meltzer CC; Kupfer DJ
Am J Psychiatry; 1999 May; 156(5):683-9. PubMed ID: 10327899
[TBL] [Abstract][Full Text] [Related]
3. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
5. Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation.
Reynolds CF; Smith GS; Dew MA; Mulsant BH; Miller MD; Schlernitzauer M; Stack JA; Houck PR; Pollock BG
Am J Geriatr Psychiatry; 2005 May; 13(5):353-8. PubMed ID: 15879583
[TBL] [Abstract][Full Text] [Related]
6. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.
Caliyurt O; Guducu F
J Affect Disord; 2005 Sep; 88(1):75-8. PubMed ID: 15967511
[TBL] [Abstract][Full Text] [Related]
7. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
9. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
Gorgulu Y; Caliyurt O
Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.
Pae CU; Kim YJ; Won WY; Kim HJ; Lee S; Lee CU; Lee SJ; Kim DW; Lee C; Min WS; Kim CC; Paik IH; Serretti A
Hum Psychopharmacol; 2004 Jan; 19(1):25-9. PubMed ID: 14716708
[TBL] [Abstract][Full Text] [Related]
11. Partial sleep deprivation therapy combined with sertraline affects subjective sleep quality in major depressive disorder.
Caliyurt O; Guducu F
Sleep Med; 2005 Nov; 6(6):555-9. PubMed ID: 15994121
[TBL] [Abstract][Full Text] [Related]
12. Time course of response to paroxetine: influence of plasma level.
Gex-Fabry M; Gervasoni N; Eap CB; Aubry JM; Bondolfi G; Bertschy G
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):892-900. PubMed ID: 17395353
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of sleep deprivation in depression.
Giedke H; Schwärzler F
Sleep Med Rev; 2002 Oct; 6(5):361-77. PubMed ID: 12531127
[TBL] [Abstract][Full Text] [Related]
14. The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome.
Hernandez CR; Smith GS; Houck PR; Pollock BG; Mulsant B; Dew MA; Reynolds CF
Psychiatry Res; 2000 Dec; 97(1):41-9. PubMed ID: 11104856
[TBL] [Abstract][Full Text] [Related]
15. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Baldwin D; Bridgman K; Buis C
J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
[TBL] [Abstract][Full Text] [Related]
18. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
19. Late-onset major depression: clinical and treatment-response variability.
Driscoll HC; Basinski J; Mulsant BH; Butters MA; Dew MA; Houck PR; Mazumdar S; Miller MD; Pollock BG; Stack JA; Schlernitzauer MA; Reynolds CF
Int J Geriatr Psychiatry; 2005 Jul; 20(7):661-7. PubMed ID: 16021664
[TBL] [Abstract][Full Text] [Related]
20. Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression.
Smith GS; Reynolds CF; Houck PR; Dew MA; Ma Y; Mulsant BH; Pollock BG
Am J Geriatr Psychiatry; 2002; 10(5):561-7. PubMed ID: 12213690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
